BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29207145)

  • 1. MicroRNA-133a acts as a tumour suppressor in breast cancer through targeting LASP1.
    Sui Y; Zhang X; Yang H; Wei W; Wang M
    Oncol Rep; 2018 Feb; 39(2):473-482. PubMed ID: 29207145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
    Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L
    Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
    Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
    Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
    Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor-suppressive function of miR-1 by targeting LASP1 and TAGLN2 in esophageal squamous cell carcinoma.
    Du YY; Zhao LM; Chen L; Sang MX; Li J; Ma M; Liu JF
    J Gastroenterol Hepatol; 2016 Feb; 31(2):384-93. PubMed ID: 26414725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer.
    Nishikawa R; Goto Y; Sakamoto S; Chiyomaru T; Enokida H; Kojima S; Kinoshita T; Yamamoto N; Nakagawa M; Naya Y; Ichikawa T; Seki N
    Cancer Sci; 2014 Jul; 105(7):802-11. PubMed ID: 24815849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-133b Inhibits Proliferation, Cellular Migration, and Invasion via Targeting LASP1 in Hepatocarcinoma Cells.
    Li H; Xiang Z; Liu Y; Xu B; Tang J
    Oncol Res; 2017 Sep; 25(8):1269-1282. PubMed ID: 28117027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-665 suppresses the progression of diffuse large B cell lymphoma (DLBCL) through targeting LIM and SH3 protein 1 (LASP1).
    Wang Y; Guo D; Li B; Wang Y; Wang B; Wang Z; Wang M; Teng Q
    Leuk Res; 2022 Jan; 112():106769. PubMed ID: 34875555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.
    Jiang N; Jiang X; Chen Z; Song X; Wu L; Zong D; Song D; Yin L; Wang D; Chen C; Bian X; He X
    J Exp Clin Cancer Res; 2017 Oct; 36(1):138. PubMed ID: 28982387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells.
    Wang C; Zheng X; Shen C; Shi Y
    J Exp Clin Cancer Res; 2012 Jun; 31(1):58. PubMed ID: 22713668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-326 inhibits cell proliferation and invasion, activating apoptosis in hepatocellular carcinoma by directly targeting LIM and SH3 protein 1.
    Hu S; Ran Y; Chen W; Zhang Y; Xu Y
    Oncol Rep; 2017 Sep; 38(3):1569-1578. PubMed ID: 28713953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-133a acts as a tumor suppressor in lung cancer progression by regulating the LASP1 and TGF-β/Smad3 signaling pathway.
    Shen Y; Yang Y; Li Y
    Thorac Cancer; 2020 Dec; 11(12):3473-3481. PubMed ID: 33074595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circ_0023028 contributes to the progression of laryngeal squamous cell carcinoma by upregulating LASP1 through miR-486-3p.
    Zheng Y; Duan L; Yang Y; Luo D; Yan B
    Mol Cell Biochem; 2021 Aug; 476(8):2951-2961. PubMed ID: 33755879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LASP1 promotes glioma cell proliferation and migration and is negatively regulated by miR-377-3p.
    Liu Y; Gao Y; Li D; He L; Iw L; Hao B; Chen X; Cao Y
    Biomed Pharmacother; 2018 Dec; 108():845-851. PubMed ID: 30372896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-218 inhibits the proliferation, migration, and invasion and promotes apoptosis of gastric cancer cells by targeting LASP1.
    Wang LL; Wang L; Wang XY; Shang D; Yin SJ; Sun LL; Ji HB
    Tumour Biol; 2016 Nov; 37(11):15241-15252. PubMed ID: 27696291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration.
    Hailer A; Grunewald TG; Orth M; Reiss C; Kneitz B; Spahn M; Butt E
    Oncotarget; 2014 Jun; 5(12):4144-4153. PubMed ID: 24980827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsa_circ_0004370 promotes esophageal cancer progression through miR-1294/LASP1 pathway.
    Zhang Z; Lin W; Gao L; Chen K; Yang C; Zhuang L; Peng S; Kang M; Lin J
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of long noncoding RNA breast cancer anti-estrogen resistance 4 inhibits cell proliferation, invasion, and migration in esophageal squamous cell carcinoma by regulating the microRNA-181c-5p/LIM and SH3 protein 1 axis.
    Ke S; Fang M; Li R; Wang J; Lu J
    Bioengineered; 2022 May; 13(5):12998-13010. PubMed ID: 35611706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-203 inhibits the migration and invasion of esophageal squamous cell carcinoma by regulating LASP1.
    Takeshita N; Mori M; Kano M; Hoshino I; Akutsu Y; Hanari N; Yoneyama Y; Ikeda N; Isozaki Y; Maruyama T; Akanuma N; Miyazawa Y; Matsubara H
    Int J Oncol; 2012 Nov; 41(5):1653-61. PubMed ID: 22940702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-203 inhibits invasion and induces apoptosis of laryngeal cancer cells via targeting LASP1.
    Tan J; Jing YY; Han L; Zheng HW; Shen JX; Zhang LH; Yu LS
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6350-6357. PubMed ID: 30338803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.